MSN Laboratories
Hyderabad, India· Est.
Indian pharma firm delivering affordable small‑molecule APIs, generics, and contract manufacturing services worldwide.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Indian pharma firm delivering affordable small‑molecule APIs, generics, and contract manufacturing services worldwide.
Infectious DiseasesOncologyBiosimilars
Technology Platform
Large‑scale synthetic chemistry for small‑molecule APIs combined with advanced formulation development and end‑to‑end contract manufacturing services.
Opportunities
Expanding demand for affordable generics and contract manufacturing services in emerging markets, and diversification into biosimilars and oncology generics.
Risk Factors
Regulatory compliance challenges, intense price competition, and potential supply‑chain disruptions could affect margins and market share.
Competitive Landscape
Competes with Indian API and generic manufacturers such as Sun Pharma, Cipla, and Lupin, differentiating through ultra‑low pricing, a broad API portfolio, and integrated CRAMS capabilities.